The BRAF and NRAS mutations are mutually exclusive in melanomas, suggesting that mutation in single gene locus is enough to over-activate the downstream Extracellular signal-regulated kinase (ERK) pathway [54]. The gene discussed is NRAS; the disease is melanoma.